Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dr Reddys Laboratories ADR repsg 1 Ord Shs RDY

Healthcare
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The... see more

Recent & Breaking News (NYSE:RDY)

Dr. Reddy's Q1 FY14 Financial Results

Business Wire July 30, 2013

Dr. Reddy's Announces the Launch of Donepezil Hydrochloride Tablets, 23 mg

Business Wire July 28, 2013

Dr. Reddy's to Release Q1 FY14 Results on July 30, 2013

Business Wire July 19, 2013

Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F

Business Wire July 12, 2013

Dr. Reddy's Announces the Launch of Decitabine for Injection

Business Wire July 12, 2013

Dr. Reddy's Announces the Launch of Lamotrigine Extended-Release Tablets

Business Wire June 26, 2013

Research Abstracts, Phase 2 Results, and Market Availability of Formulations and Treatments- Research Report on Teva, Forest, Pharmacyclics, Cubist, and Dr. Reddy's

PR Newswire June 19, 2013

Fujifilm and Dr. Reddy's Call Off Joint Venture for Generic Drugs in Japan

Business Wire June 3, 2013

Free Research Reports on RDY, TAM, VELT and XONE Issued by the Bedford Report

Marketwired May 15, 2013

Dr. Reddy's Q4 & FY13 Financial Results

Business Wire May 14, 2013

Dr. Reddy's to Release Q4 and Full Year FY13 Results on May 14, 2013

Business Wire April 30, 2013

Dr. Reddy's Announces the Relocation of Their North America Headquarters and Establishment of a R&D Center in Princeton, NJ, USA

Business Wire April 9, 2013

Dr. Reddy's Announces the Launch of Zoledronic Acid Injection

Business Wire April 4, 2013

Dr. Reddy's Appoints GV Prasad as Chairman and Satish Reddy as Vice-Chairman of the Company

Business Wire April 1, 2013

Dr. Reddy's Announces the Launch of Zenatane(TM) (Isotretinoin Capsules USP)

Business Wire March 29, 2013

Dr. Reddy's and Nordion Inc. (formerly MDS Inc.) Settle Claims

Business Wire March 22, 2013

Dr. Reddy's Laboratories Announces Dr. K. Anji Reddy Has Passed Away

Business Wire March 15, 2013

Dr. Reddy's Announces the Launch of Zoledronic Acid Injection

Business Wire March 5, 2013

Dr. Reddy's Holds 98.6% of the Shares in OctoPlus after the Post Closing Acceptance Period

Business Wire February 28, 2013

Free Research Report on Itron, Inc., Dr. Reddy's Laboratories Ltd., Intrepid Potash, Inc., Pinnacle Entertainment, Inc. and Sovran Self Storage, Inc.

Marketwired February 15, 2013